News | Artificial Intelligence | September 21, 2017

SIIM Announces Keynote Speakers for Conference on Machine Intelligence in Medical Imaging

Google and FDA experts to provide innovative insights into machine intelligence in medical imaging

SIIM Announces Keynote Speakers for Conference on Machine Intelligence in Medical Imaging

September 21, 2017 — The Society for Imaging Informatics in Medicine (SIIM) recently announced several corporate and government experts as the keynote speakers for the 2nd SIIM Scientific Conference on Machine Intelligence in Medical Imaging (C-MIMI). The conference will be held Sept. 26-27 in Baltimore, Md., at the Johns Hopkins University.

Presentations will feature:

  • Gregory J. Moore, M.D., Ph.D., VP Healthcare, Google Cloud. Moore, who will discuss "Intelligent Medical Imaging at Scale: Insights from Applying Deep Learning," is an engineer (MIT Ph.D.), practicing neuroradiologist, informaticist and innovator. As Google's senior global healthcare leader, Moore leads the healthcare vertical for Google Cloud and partners closely with various Google teams (i.e. Brain) and the Alphabet companies (i.e. DeepMind), to guide and develop innovative healthcare products and solutions leveraging machine learning/artificial intelligence (AI) and advanced analytics at scale;
  • Berkman Sahiner, Ph.D., leader, DIDSR Image Analysis Laboratory, U.S. Food and Drug Administration. As the leader at the Division of Imaging, Diagnostics and Software Reliability at the FDA, Sahiner performs research related to evaluation of medical imaging and computer-assisted diagnosis devices. In his talk, "FDA Perspectives on Machine Learning and Software Development for Medical Image Interpretation", Sahiner will discuss some of the recent developments, such as a newly-approved DeNovo device, as well as the new PDA Pre-Cert pilot for software devices.

 

C-MIMI brings together informatics and machine learning experts to discuss state-of-the-art methods, best practices and tools for research, as well as regulatory and business considerations.

"The SIIM C-MIMI conference has become the must-attend event for medical imaging researchers in machine intelligence. The research presented here will advance the state of the science in our field. We are thrilled to host it in Baltimore this year at Johns Hopkins," said Paul Nagy, Ph.D., SIIM chair, deputy director, JHM Technology Innovation Center, associate professor, Johns Hopkins University School of Medicine.

In addition to the Google Cloud and FDA keynote addresses, the NVIDIA Deep Learning Institute and over 30 scientific abstract presentations will highlight this conference.

Related Content

VIDEO: Examples of Artificial Intelligence in Medical Imaging Diagnostics

VIDEO: Development of Artificial Intelligence to Aid Radiology

How Artificial Intelligence Will Change Medical Imaging

VIDEO: The Future of Imaging Informatics

For more information: www.siim.org/2017cmimi

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).